| Literature DB >> 24710614 |
Diana L Martin1, Morgan Marks2, Gerson Galdos-Cardenas2, Robert H Gilman2, Brook Goodhew2, Lisbeth Ferrufino2, Anthony Halperin2, Gerardo Sanchez2, Manuela Verastegui2, Patricia Escalante2, Cesar Naquira2, Michael Z Levy2, Caryn Bern2.
Abstract
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a major cause of morbidity and mortality in Central and South America. Geographic variations in the sensitivity of serologic diagnostic assays to T. cruzi may reflect differences in T. cruzi exposure. We measured parasite-specific T-cell responses among seropositive individuals in two populations from South America with widely varying antibody titers against T. cruzi. Antibody titers among seropositive individuals were significantly lower in Arequipa, Peru compared with Santa Cruz, Bolivia. Similarly, the proportion of seropositive individuals with positive T-cell responses was lower in Peru than Bolivia, resulting in overall lower frequencies of interferon-γ (IFNγ)-secreting cells from Peruvian samples. However, the magnitude of the IFNγ response was similar among the IFNγ responders in both locations. These data indicate that immunological discrepancies based on geographic region are reflected in T-cell responses as well as antibody responses. © The American Society of Tropical Medicine and Hygiene.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24710614 PMCID: PMC4047731 DOI: 10.4269/ajtmh.13-0391
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345